Seres Therapeutics Inc (MCRB)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Seres Therapeutics Inc-Aktie (MCRB)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	0.351	-	-	-	-
Operating Expenses	8.25% 22.83	24.88	27.24	28.84	29.17
Benefits Costs and Expenses	-7.853	-	-	-	-
Costs And Expenses	-7.853	-	-	-	-
Operating Income/Loss	9.66% -22.48	-24.88	-27.24	-28.84	-29.17
Nonoperating Income/Loss	510.45% 30.68	5.026	59.92	13.20	-21.86
Income/Loss From Continuing Operations Before Tax	141.32% 8.204	-19.86	32.68	-15.64	-51.03
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	141.32% 8.204	-19.86	32.68	-15.64	-51.03
Income/Loss From Discontinued Operations, Net Of Tax	-	-	-	-	139.81
Net Income/Loss	141.32% 8.204	-19.86	32.68	-15.64	88.78
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.17% 8.7587	8.7437	8.7032	5.3033	152.65
Diluted Average Shares	0.32% 8.7715	8.7437	8.7147	5.3033	152.65
Basic Earnings Per Share	141.41% 0.94	-2.27	3.76	-0.11	0.58
Diluted Earnings Per Share	141.41% 0.94	-2.27	3.75	-0.11	0.58
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%